Clinical trial
Omalizumab for the Monotherapy Treatment of Patients With Allergy to Foods of Plant Origin Due to Sensitization to Lipid Transfer Proteins (LTPs) and Profilin
NCT07073404 is registered in ClinicalTrials.gov with Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Omalizumab for the Monotherapy Treatment of Patients With Allergy to Foods of Plant Origin Due to Sensitization to Lipid Transfer Proteins (LTPs) and Profilin
- Lead sponsor
- Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- January 31, 2026
- Completion date
- December 31, 2027
- Enrollment
- 37 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
food allergies